A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients

Frontiers in Microbiology
Mohammad A TariqDarren L Smith

Abstract

Pseudomonas aeruginosa (Pa), normally a soil commensal, is an important opportunistic pathogen in Cystic Fibrosis (CF) and non-Cystic Fibrosis Bronchiectasis (nCFBR). Persistent infection correlates with accelerated decline in lung function and early mortality. The horizontal transfer of DNA by temperate bacteriophages can add gene function and selective advantages to their bacterial host within the constrained environment of the lower lung. In this study, we chemically induce temperate bacteriophages from clonal cultures of Pa and identify their mixed viral communities employing metagenomic approaches. We compared 92 temperate phage metagenomes stratified from these clinical backgrounds (47 CF and 45 nCFBR Pa isolates) using MG-RAST and GeneWise2. KEGG analysis shows the complexity of temperate phage accessory gene carriage increases with duration and severity of the disease. Furthermore, we identify the presence of Ig-like motifs within phage structural genes linked to bacterial adhesion and carbohydrate binding including Big_2, He_Pig, and Fn3. This study provides the first clinical support to the proposed bacteriophage adherence to mucus (BAM) model and the evolution of phages interacting at these mucosal surfaces over time.

References

Mar 27, 1999·Journal of Bacteriology·A MatsushiroT Honda
Dec 11, 1999·Nucleic Acids Research·M Kanehisa, S Goto
Apr 23, 2005·Science·Susannah Green TringeEdward M Rubin
Sep 20, 2005·Nature Structural & Molecular Biology·Stephen A McMahonPartho Ghosh
Apr 25, 2006·Journal of Molecular Biology·James S FraserAlan R Davidson
Sep 7, 2006·Journal of Clinical Microbiology·Michael BoudewijnsWillem J G Melchers
Sep 4, 2007·Current Opinion in Microbiology·James S FraserAlan R Davidson
Jan 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Peter C FineranGeorge P C Salmond
Jan 20, 2009·Bioinformatics·Andrew M WaterhouseGeoffrey J Barton
Nov 28, 2009·Trends in Microbiology·David M KristensenEugene V Koonin
Mar 6, 2010·Trends in Biochemical Sciences·Travis BeddoeJames C Paton
Apr 9, 2010·Clinical Microbiology Reviews·John J Lipuma
Apr 27, 2010·FEBS Letters·Luciane V MelloDaniel J Rigden
Jun 22, 2010·Bioinformatics·Daniel BlankenbergUNKNOWN Galaxy Team
Aug 13, 2010·Current Gastroenterology Reports·Young S Kim, Samuel B Ho
Sep 10, 2010·Journal of Molecular Biology·Lisa G PellKaren L Maxwell
Jan 15, 2011·Clinical Microbiology Reviews·Alan R HauserSusanna A McColley
Oct 21, 2011·Journal of Clinical Microbiology·Vibeke B RudkjøbingThomas Bjarnsholt
Dec 20, 2011·Current Opinion in Microbiology·Gunnar C Hansson
Apr 18, 2012·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Anton BankevichPavel A Pevzner
Jul 18, 2012·BMC Genomics·Darren L SmithHeather E Allison
Jan 1, 2013·Bacteriophage·E Fidelma BoydNityananda Chowdhury
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jeremy J BarrForest Rohwer
Mar 22, 2014·BMC Bioinformatics·Simon RouxFrançois Enault
Jul 25, 2014·Nature Communications·Bas E DutilhRobert A Edwards

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

BLASTn
RAST
IBDA
MG
KEGG
IDBA
Velvet assembler
Jalview
GeneWise2
excel

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.